Impact of sphingomyelin levels on coronary heart disease and left ventricular systolic function in humans
Open Access
- 26 April 2011
- journal article
- Published by Springer Nature in Nutrition & Metabolism
- Vol. 8 (1) , 25
Abstract
Sphingomyelin (SM) is an abundant phospholipid in cell membranes and in lipoproteins. In human plasma, SM is mainly found in atherogenic lipoproteins; therefore, higher levels of SM may promote atherogenesis. We investigated the relations between plasma SM levels and the presence of angiographic coronary heart disease (CHD) and left ventricular systolic dysfunction. We studied 732 patients referred for coronary angiography. Median SM levels were higher among patients with CHD and in those with LV systolic dysfunction (LVEF<50%) than in patients without CHD or LV dysfunction. SM levels were significantly correlated with fibrinogen levels, diabetes, apoB, and triglyceride levels. On multivariate analyses, higher median SM levels were associated with a higher risk of CHD and lower LV ejection fraction. The pro-atherogenic property of plasma SM might be related to 1) CHD; 2) LV systolic dysfunction; and 3) metabolism of apoB-containing or triglyceride-rich lipoproteins.Keywords
This publication has 33 references indexed in Scilit:
- Association of Plasma Sphingomyelin Levels and Incident Coronary Heart Disease Events in an Adult PopulationArteriosclerosis, Thrombosis, and Vascular Biology, 2010
- Macrophage Sphingomyelin Synthase 2 Deficiency Decreases Atherosclerosis in MiceCirculation Research, 2009
- [Changes of nitric oxide and endothelin serum level after carotid balloon denudation or stent assisted angioplasty: an experimental and clinical observation].2009
- Sphingomyelin Synthase 2 Deficiency Attenuates NFκB ActivationArteriosclerosis, Thrombosis, and Vascular Biology, 2008
- Rapid, specific, and sensitive measurements of plasma sphingomyelin and phosphatidylcholineJournal of Lipid Research, 2006
- Inhibition of Sphingomyelin Synthesis Reduces Atherogenesis in Apolipoprotein E–Knockout MiceCirculation, 2004
- Glutathione Regulation of Neutral Sphingomyelinase in Tumor Necrosis Factor-α-induced Cell DeathJournal of Biological Chemistry, 1998
- The sphingomyelin–ceramide pathway participates in cytokine regulation of C-reactive protein and serum amyloid A, but not α-fibrinogenBiochemical Journal, 1997
- Sphingosine Mediates the Immediate Negative Inotropic Effects of Tumor Necrosis Factor-α in the Adult Mammalian Cardiac MyocyteJournal of Biological Chemistry, 1997
- Effects of dietary supplementation with marine lipid concentrate on the plasma lipoprotein composition of hypercholesterolemic patientsAtherosclerosis, 1989